Three Forces Drive Bacterial Toxin Evolution

A new study published in Nature Ecology & Evolution reveals that the diversity of nonribosomal peptides, a class of compounds used by bacteria as weapons in microbial competition, is shaped by the interplay of at least three distinct evolutionary forces. The research, led by Helge Bode at the Max Planck Institute for Terrestrial Microbiology and Georg Hochberg from the University of Marburg, focuses on GameXPeptide, an insecticide produced by the bacteria Xenorhabdus and Photorhabdus. These bacteria exist in a complex three-way partnership with nematodes and insect larvae, residing in the nematode gut before being released to kill the insect host.

This dynamic creates intense evolutionary pressure, as insects develop resistance and bacteria must adapt their toxins. The study illuminates for the first time how natural selection, genetic drift, and recombination bias collectively drive the evolution of these versatile natural products, which are also chemically optimized by humans for use in medicines. Nonribosomal peptides are synthesized by large bacterial enzyme machineries known as nonribosomal peptide synthetases, or NRPS.

These enzymes function like molecular assembly lines, where specialized modules string together amino acids one by one to build complex peptides. Unlike ordinary proteins, which evolve primarily through random mutations of individual DNA building blocks, NRPS evolve through a process called recombination, involving the exchange of entire gene segments. This results in new combinations of modules and, consequently, new peptides with altered chemical properties.

However, this frequent recombination has historically obscured the evolutionary history of these enzymes, pushing classical methods of evolutionary research to their limits. Standard statistical tests designed to distinguish natural selection from random evolution are typically calibrated for changes at individual DNA positions, making them ineffective for analyzing the exchange of large DNA segments. To address this methodological challenge, the research team focused on the GxpS synthetase, the enzyme machinery responsible for producing GameXPeptides.

Because GxpS consists of only five modules, it was manageable enough to reconstruct its full evolutionary history through phylogenetic analyses. Through these reconstructions, the researchers discovered a surprisingly large diversity of previously unknown GameXPeptide variants, identifying a total of 49 distinct compounds ranging from shortened cyclic tetrapeptides to an extended hexapeptide. A particularly striking finding was the presence of convergent evolution, where several bacterial lineages that had evolved independently produced identical or very similar peptide structures through separate evolutionary routes.

To understand the chronological order in which these variants arose, the team reconstructed the last common ancestor of the GxpS synthetase by restoring approximately 15,000 base pairs of genetic material, assembling them into a functional gene, and expressing it in Escherichia coli. This experimental resurrection allowed the researchers to determine what the ancestral enzyme looked like and to map the sequence of events that led to today's diverse variants. The analysis revealed that natural selection alone does not account for the diversity of GameXPeptides.

Instead, at least three distinct forces act in concert: natural selection, genetic drift, and a phenomenon the researchers term recombination bias. To distinguish between selective and neutral evolution, the team used a statistical comparison based on homotypic recombinations. These are recombination events where two modules with the same specificity are swapped, resulting in no structural change to the peptide.

These events served as a benchmark for what would be expected under neutral evolution. In contrast, heterotypic recombinations, which actually change the amino acid sequence, were found to occur significantly more often in regions of the enzyme critical for substrate specificity. This pattern provided clear evidence of positive selection.

Experimental tests with four different insect species confirmed that different GXP variants kill different insects with varying degrees of efficiency, linking specific peptide structures to specific biological outcomes. Simultaneously, the researchers found strong evidence for genetic drift, which involves changes in allele frequencies without any discernible selective advantage. This suggests that a substantial portion of GameXPeptide diversity arose through the random fixation of neutral variants.

This effect is particularly favored by the bacteria's unique life cycle. Each nematode is initially colonized by only a small number of bacterial cells, creating population bottlenecks that limit population size and amplify the role of chance in evolution. The third force, recombination bias, refers to the observation that not every recombination is equally likely.

The researchers discovered that recombinations occur preferentially between modules that are similar at the sequence level. Since similar modules are found mainly within the same gene cluster, nonribosomal peptide synthetases in practice incorporate primarily those amino acids already represented in the cluster. This is notable because these enzymes could theoretically draw on a repertoire of up to 300 different amino acid variants.

This bias creates a self-reinforcing mechanism that leads to an evolutionary tunnel vision. Each recombination within the cluster makes the participating modules even more similar to one another, which in turn makes future recombinations between the same partners increasingly likely. This mechanism may explain why the same variants so often evolve convergently across different lineages.

It suggests that these variants are not necessarily the most effective weapons, but rather the ones that are particularly easy to produce given the constraints of the recombination process. The implications of this work extend well beyond the specific case of GameXPeptides. Many well-known antibiotics are also nonribosomal peptides.

If their evolutionary histories likewise conceal numerous undiscovered recombination events, new bioactive variants may be hidden within their genetic sequences. These hidden variants could potentially overcome existing antibiotic resistances or possess novel mechanisms of action that have not yet been characterized. The methods developed in this study offer, for the first time, a systematic way to uncover this hidden diversity by distinguishing between selective, neutral, and biased evolutionary forces.

By applying this framework to other natural product families, such as polyketide synthases, researchers may be able to decipher the evolutionary forces acting on these enzymes and identify new drug candidates.

Subject of Research: Bacteria constantly reinvent their weapons

Article Title: Bacteria constantly reinvent their weapons

Article References: Bacteria constantly reinvent their weapons. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: Bacteria, constantly, reinvent, weapons, scientific research, peer-reviewed research